Literature DB >> 34425966

Gene-Targeted, CREB-Mediated Induction of ΔFosB Controls Distinct Downstream Transcriptional Patterns Within D1 and D2 Medium Spiny Neurons.

Casey K Lardner1, Yentl van der Zee1, Molly S Estill1, Hope G Kronman1, Marine Salery1, Ashley M Cunningham1, Arthur Godino1, Eric M Parise1, Jee Hyun Kim2, Rachael L Neve3, Li Shen1, Peter J Hamilton4, Eric J Nestler5.   

Abstract

BACKGROUND: The onset and persistence of addiction phenotypes are, in part, mediated by transcriptional mechanisms in the brain that affect gene expression and, subsequently, neural circuitry. ΔFosB is a transcription factor that accumulates in the nucleus accumbens (NAc)-a brain region responsible for coordinating reward and motivation-after exposure to virtually every known rewarding substance, including cocaine and opioids. ΔFosB has also been shown to directly control gene transcription and behavior downstream of both cocaine and opioid exposure, but with potentially different roles in D1 and D2 medium spiny neurons (MSNs) in NAc.
METHODS: To clarify MSN subtype-specific roles for ΔFosB and investigate how these coordinate the actions of distinct classes of addictive drugs in NAc, we developed a CRISPR (clustered regularly interspaced short palindromic repeats)/Cas9-based epigenome editing tool to induce endogenous ΔFosB expression in vivo in the absence of drug exposure. After inducing ΔFosB in D1- or D2-MSNs or both, we performed RNA sequencing on bulk male and female NAc tissue (n = 6-8/group).
RESULTS: We found that ΔFosB induction elicits distinct transcriptional profiles in NAc by MSN subtype and by sex, establishing for the first time that ΔFosB mediates different transcriptional effects in males versus females. We also demonstrated that changes in D1-MSNs, but not those in D2-MSNs or both, significantly recapitulate changes in gene expression induced by cocaine self-administration.
CONCLUSIONS: Together, these findings demonstrate the efficacy of a novel molecular tool for studying cell type-specific transcriptional mechanisms and shed new light on the activity of ΔFosB, a critical transcriptional regulator of drug addiction.
Copyright © 2021 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cocaine; Gene editing; Nucleus accumbens; Opioids; Substance use disorder; ΔFosB

Mesh:

Substances:

Year:  2021        PMID: 34425966      PMCID: PMC8501456          DOI: 10.1016/j.biopsych.2021.06.017

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   12.810


  49 in total

Review 1.  DeltaFosB: a sustained molecular switch for addiction.

Authors:  E J Nestler; M Barrot; D W Self
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

2.  Serum response factor and cAMP response element binding protein are both required for cocaine induction of ΔFosB.

Authors:  Vincent Vialou; Jian Feng; Alfred J Robison; Stacy M Ku; Deveroux Ferguson; Kimberly N Scobie; Michelle S Mazei-Robison; Ezekiell Mouzon; Eric J Nestler
Journal:  J Neurosci       Date:  2012-05-30       Impact factor: 6.167

Review 3.  Transcriptional and epigenetic mechanisms of addiction.

Authors:  Alfred J Robison; Eric J Nestler
Journal:  Nat Rev Neurosci       Date:  2011-10-12       Impact factor: 34.870

4.  Locus-specific epigenetic remodeling controls addiction- and depression-related behaviors.

Authors:  Elizabeth A Heller; Hannah M Cates; Catherine J Peña; Haosheng Sun; Ningyi Shao; Jian Feng; Sam A Golden; James P Herman; Jessica J Walsh; Michelle Mazei-Robison; Deveroux Ferguson; Scott Knight; Mark A Gerber; Christian Nievera; Ming-Hu Han; Scott J Russo; Carol S Tamminga; Rachael L Neve; Li Shen; H Steve Zhang; Feng Zhang; Eric J Nestler
Journal:  Nat Neurosci       Date:  2014-10-27       Impact factor: 24.884

Review 5.  In vivo locus-specific editing of the neuroepigenome.

Authors:  Yun Young Yim; Collin D Teague; Eric J Nestler
Journal:  Nat Rev Neurosci       Date:  2020-07-23       Impact factor: 34.870

6.  Cell-Type-Specific Epigenetic Editing at the Fosb Gene Controls Susceptibility to Social Defeat Stress.

Authors:  Peter J Hamilton; Dominika J Burek; Sonia I Lombroso; Rachael L Neve; Alfred J Robison; Eric J Nestler; Elizabeth A Heller
Journal:  Neuropsychopharmacology       Date:  2017-05-02       Impact factor: 7.853

7.  Induction of chronic Fos-related antigens in rat brain by chronic morphine administration.

Authors:  H E Nye; E J Nestler
Journal:  Mol Pharmacol       Date:  1996-04       Impact factor: 4.436

Review 8.  Drug-activated cells: From immediate early genes to neuronal ensembles in addiction.

Authors:  Marine Salery; Arthur Godino; Eric J Nestler
Journal:  Adv Pharmacol       Date:  2021-02-19

9.  A dopamine-induced gene expression signature regulates neuronal function and cocaine response.

Authors:  Katherine E Savell; Jennifer J Tuscher; Morgan E Zipperly; Corey G Duke; Robert A Phillips; Allison J Bauman; Saakshi Thukral; Faraz A Sultan; Nicholas A Goska; Lara Ianov; Jeremy J Day
Journal:  Sci Adv       Date:  2020-06-24       Impact factor: 14.136

10.  Fosb Induction in Nucleus Accumbens by Cocaine Is Regulated by E2F3a.

Authors:  Hannah M Cates; Casey K Lardner; Rosemary C Bagot; Rachael L Neve; Eric J Nestler
Journal:  eNeuro       Date:  2019-04-01
View more
  3 in total

1.  ΔFOSB: A Potentially Druggable Master Orchestrator of Activity-Dependent Gene Expression.

Authors:  Alfred J Robison; Eric J Nestler
Journal:  ACS Chem Neurosci       Date:  2022-01-12       Impact factor: 4.418

2.  Methylation and expression quantitative trait locus rs6296 in the HTR1B gene is associated with susceptibility to opioid use disorder.

Authors:  Yunxiao Li; Ye Lu; Qiaoli Xie; Xiaofeng Zeng; Rui Zhang; Wei Dang; Yongsheng Zhu; Jianbo Zhang
Journal:  Psychopharmacology (Berl)       Date:  2022-04-19       Impact factor: 4.415

Review 3.  Sex differences in methamphetamine use disorder perused from pre-clinical and clinical studies: Potential therapeutic impacts.

Authors:  Atul P Daiwile; Subramaniam Jayanthi; Jean Lud Cadet
Journal:  Neurosci Biobehav Rev       Date:  2022-04-20       Impact factor: 9.052

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.